BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 38062767)

  • 1. Presumed Pathogenic Germ Line and Somatic Variants in African American Thyroid Cancer.
    Hurst ZA; Liyanarachchi S; Brock P; He H; Nabhan F; Veloski C; Toland AE; Ringel MD; Jhiang SM
    Thyroid; 2024 Mar; 34(3):378-387. PubMed ID: 38062767
    [No Abstract]   [Full Text] [Related]  

  • 2. Risk Haplotypes Uniquely Associated with Radioiodine-Refractory Thyroid Cancer Patients of High African Ancestry.
    Hurst Z; Liyanarachchi S; He H; Brock P; Sipos J; Nabhan F; Kebebew E; Green P; Cote GJ; Sherman S; Walker CJ; Chang YS; Xue S; Hollingsworth B; Li W; Genutis L; Menq E; de la Chapelle A; Jhiang SM
    Thyroid; 2019 Apr; 29(4):530-539. PubMed ID: 30654714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of Rare Variants Predisposing to Thyroid Cancer.
    Wang Y; Liyanarachchi S; Miller KE; Nieminen TT; Comiskey DF; Li W; Brock P; Symer DE; Akagi K; DeLap KE; He H; Koboldt DC; de la Chapelle A
    Thyroid; 2019 Jul; 29(7):946-955. PubMed ID: 30957677
    [No Abstract]   [Full Text] [Related]  

  • 4. Thyroid Carcinomas That Occur in Familial Adenomatous Polyposis Patients Recurrently Harbor Somatic Variants in
    Nieminen TT; Walker CJ; Olkinuora A; Genutis LK; O'Malley M; Wakely PE; LaGuardia L; Koskenvuo L; Arola J; Lepistö AH; Brock P; Yilmaz AS; Eisfeld AK; Church JM; Peltomäki P; de la Chapelle A
    Thyroid; 2020 Mar; 30(3):380-388. PubMed ID: 32024448
    [No Abstract]   [Full Text] [Related]  

  • 5.
    Brock P; Liynarachchi S; Nieminen TT; Chan C; Kohlmann W; Stout LA; Yao S; La Greca A; Jensen KE; Kolesar JM; Salhia B; Gulhati P; Hicks JK; Ringel MD
    Thyroid; 2024 Apr; 34(4):477-483. PubMed ID: 38279823
    [No Abstract]   [Full Text] [Related]  

  • 6. Genetic predisposition for nonmedullary thyroid cancer.
    Nagy R; Ringel MD
    Horm Cancer; 2015 Feb; 6(1):13-20. PubMed ID: 25338077
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In patients with thyroid cancer of follicular cell origin, a family history of nonmedullary thyroid cancer in one first-degree relative is associated with more aggressive disease.
    Mazeh H; Benavidez J; Poehls JL; Youngwirth L; Chen H; Sippel RS
    Thyroid; 2012 Jan; 22(1):3-8. PubMed ID: 22136209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Familial Aggregation and Heritability of Nonmedullary Thyroid Cancer in an Asian Population: A Nationwide Cohort Study.
    Lin HT; Liu FC; Lin SF; Kuo CF; Chen YY; Yu HP
    J Clin Endocrinol Metab; 2020 Jul; 105(7):. PubMed ID: 32333767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Familial nonmedullary thyroid carcinoma.
    Malchoff CD; Malchoff DM
    Cancer Control; 2006 Apr; 13(2):106-10. PubMed ID: 16735984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The FOXE1 locus is a major genetic determinant for familial nonmedullary thyroid carcinoma.
    Bonora E; Rizzato C; Diquigiovanni C; Oudot-Mellakh T; Campa D; Vargiolu M; Guedj M; ; McKay JD; Romeo G; Canzian F; Lesueur F
    Int J Cancer; 2014 May; 134(9):2098-107. PubMed ID: 24127282
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Whole Genome Sequencing Prioritizes
    Srivastava A; Giangiobbe S; Skopelitou D; Miao B; Paramasivam N; Diquigiovanni C; Bonora E; Hemminki K; Försti A; Bandapalli OR
    Front Endocrinol (Lausanne); 2021; 12():600682. PubMed ID: 33692755
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Germline Mutations for Novel Candidate Predisposition Genes in Sporadic Schwannomatosis.
    Min BJ; Kang YK; Chung YG; Seo ME; Chang KB; Joo MW
    Clin Orthop Relat Res; 2020 Nov; 478(11):2442-2450. PubMed ID: 32281771
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Non-medullary Thyroid Cancer Susceptibility Genes: Evidence and Disease Spectrum.
    Zhou J; Singh P; Yin K; Wang J; Bao Y; Wu M; Pathak K; McKinley SK; Braun D; Lubitz CC; Hughes KS
    Ann Surg Oncol; 2021 Oct; 28(11):6590-6600. PubMed ID: 33660127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of the mutational landscape of anaplastic thyroid cancer via whole-exome sequencing.
    Kunstman JW; Juhlin CC; Goh G; Brown TC; Stenman A; Healy JM; Rubinstein JC; Choi M; Kiss N; Nelson-Williams C; Mane S; Rimm DL; Prasad ML; Höög A; Zedenius J; Larsson C; Korah R; Lifton RP; Carling T
    Hum Mol Genet; 2015 Apr; 24(8):2318-29. PubMed ID: 25576899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Second Malignant Neoplasm in Familial Non-Medullary Thyroid Cancer Patients.
    Capezzone M; Sagnella A; Cantara S; Fralassi N; Maino F; Forleo R; Brilli L; Pilli T; Cartocci A; Castagna MG
    Front Endocrinol (Lausanne); 2022; 13():845954. PubMed ID: 35311228
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole exome and target sequencing identifies MAP2K5 as novel susceptibility gene for familial non-medullary thyroid carcinoma.
    Ye F; Gao H; Xiao L; Zuo Z; Liu Y; Zhao Q; Chen H; Feng W; Fu B; Sun L; Jiang X; He D; Jiang H; Yang M; Li L; Chen F; Liu X; Li S; Li Z; Jiang Y; Cheng L; Bu H
    Int J Cancer; 2019 Mar; 144(6):1321-1330. PubMed ID: 30132833
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early evolutionary divergence between papillary and anaplastic thyroid cancers.
    Capdevila J; Mayor R; Mancuso FM; Iglesias C; Caratù G; Matos I; Zafón C; Hernando J; Petit A; Nuciforo P; Cameselle-Teijeiro JM; Álvarez C; Recio JA; Tabernero J; Matias-Guiu X; Vivancos A; Seoane J
    Ann Oncol; 2018 Jun; 29(6):1454-1460. PubMed ID: 29648575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Germline Variants in Targeted Tumor Sequencing Using Matched Normal DNA.
    Schrader KA; Cheng DT; Joseph V; Prasad M; Walsh M; Zehir A; Ni A; Thomas T; Benayed R; Ashraf A; Lincoln A; Arcila M; Stadler Z; Solit D; Hyman DM; Zhang L; Klimstra D; Ladanyi M; Offit K; Berger M; Robson M
    JAMA Oncol; 2016 Jan; 2(1):104-11. PubMed ID: 26556299
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digoxin treatment reactivates in vivo radioactive iodide uptake and correlates with favorable clinical outcome in non-medullary thyroid cancer.
    Crezee T; Tesselaar MH; Nagarajah J; Corver WE; Morreau J; Pritchard C; Kimura S; Kuiper JG; van Engen-van Grunsven I; Smit JWA; Netea-Maier RT; Plantinga TS
    Cell Oncol (Dordr); 2021 Jun; 44(3):611-625. PubMed ID: 33534128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of Novel Candidate Genes for Familial Thyroid Cancer by Whole Exome Sequencing.
    Tous C; Muñoz-Redondo C; Bravo-Gil N; Gavilan A; Fernández RM; Antiñolo J; Navarro-González E; Antiñolo G; Borrego S
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175550
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.